Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 1
1(50.0%)
Early Phase 1
1(50.0%)
2Total
Phase 1(1)
Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT04142957Completed

COPD Pal Phase 1: A Self-management App in COPD

Role: collaborator

NCT05892627Early Phase 1Unknown

A Supplement on Cognitive Function and Brain Activity in Middle Age and Older Healthy Adults

Role: collaborator

NCT05878847Phase 1Unknown

Oral Supplement in Older Adults to Support Physical Fitness and Mental Well-being

Role: collaborator

All 3 trials loaded